A person’s self-efficacy plays a critical role during the chronic management process of a health condition. Assessment of self-efficacy for patients with heart diseases is essential for healthcare professionals to provide tailored interventions to help patient to manage the disease. To translate and test the psychometric properties of the Chinese version of Cardiac Self-efficacy Scale (C-CSES) as a disease-specific instrument for patients with coronary heart disease (CHD) in mainland China. The original English version of the CSES was translated into Chinese using a forward-backward translation approach. A convenience sample consisting of 224 Chinese patients with CHD were recruited from a university-affiliated hospital in Shiyan, China. The C-CSES and the General Self-efficacy Scale (GSES) were used in this study. The factor structure, convergent and discriminative validities, and internal consistency of the C-CSES were evaluated. The confirmatory factor analysis (CFA) supported a three-factor high-order structure of the C-CSES with model fit indexes (RMSEA = 0.084, CFI = 0.954, NNFI = 0.927, IFI = 0.954 and χ 2 /df = 2.572). The C-CSES has good internal consistency with a Cronbach’s alpha of 0.926. The convergent validity of the C-CSES was established with significantly moderate correlations between the C-CSES and the Chinese version of the GSES (p < 0.001). The C-CSES has also shown good discriminative validity with significant differences of cardiac self-efficacy being found between patients with and without comorbidities of hypertension, diabetes, or heart failure. The empirical data supported that the C-CSES is a valid and reliable disease-specific instrument for assessing the self-efficacy of Chinese patients with CHD.
Background/Objectives: Vital signs monitoring during blood transfusion is important but inconsistently practiced across contexts. This paper aimed to consolidate the available evidence to determine the optimal monitoring frequency that balances efficiency and safety in clinical practice. Methods: Evidence was gathered through a literature review, review of international guidelines, investigation of local practices and analysis of study institution’s retrospective data on transfusion reaction patterns. Expert opinions were consulted on the proposed changes, prior to the pilot feasibility study. Results: The majority of the reviewed guidelines and practices monitored vital signs at three time-points: before transfusion, 15 min after initiation and upon completion. However, study hospital data revealed that transfusion reactions predominantly occurred within the first two hours, particularly among males aged 50–70 who received red packed cells in the oncology wards and had abnormal pre-transfusion vital signs. Thus, the original 10-point frequency practiced by the study hospital was modified to seven time-points instead of the widely adopted three time-points: prior to blood transfusion; 15 min after commencement; 30 min at the forty-fifth minute; hourly thereafter until completion; and within 1 h post-transfusion. Conclusions: Despite existing guidelines recommending only three vital signs monitoring time-points, institutional data suggests that using seven time-points is optimal to minimize missed transfusion reactions while preventing an unnecessary workload, balancing patient safety and operational efficiency. These proposed revisions will be evaluated through an upcoming pilot trial to assess their feasibility and the impact on patient outcomes.
Acute myocardial infarction (AMI) is a leading cause of morbidity and mortality worldwide. This study aimed to test the efficacy of a newly-developed symptom self-management program on health outcomes among inpatients post-AMI. A pilot randomised, controlled trial was utilised. A convenience sample of 90 was recruited from a tertiary hospital in Singapore. Adult inpatients with post-AMI were randomly assigned to the three groups: IManage-HSet, IManage-FF or control group. Sample size was computed using power analysis. Data were collected through self-reported questionnaires and physiological instruments. Data analyses included univariate statistics, analysis of variance and repeated measure analysis of variance. Ninety participants were recruited with 30 in each group. Participants in the IManage-HSet and IManage-FF group had significantly greater relaxation (ηp2 = 0.11), lower objective stress (ηp2 =0.14), and greater knowledge (ηp2 = 0.62) than those of the control group. The two intervention groups had lower subjective stress (ηp2 = 0.04), depression (ηp2 = 0.01), and anxiety (ηp2 = 0.03) than the control but such differences did not achieve statistical significance. Furthermore, most participants reported that they were satisfied with the programs and they provided positive comments on the contents, educational materials and relaxation practice. This pilot study supports the potential benefits and feasibility of the IManage-VR and IManage-FF interventions on stress, perceived relaxation, knowledge and patient satisfaction. Contents of the symptom management interventions could be added into current cardiac rehabilitation programs. Future RCTs with multi-centered sites and larger sample size are required to further test the intervention. This study was prospectively registered with the International Standard Randomised Controlled Trial on the 5th August 2014 with registration number ISRCTN61027816.